Search research articles
Contact Us
Filters
Showing results (221-230 of 485) with videos related to
Page
of 49
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
October 11, 2014
A search for functional histamine H4 receptors in the human, guinea pig and mouse brain
Monika Feliszek, Valerie Speckmann, Daniel Schacht, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 26, 2022
Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism
Nermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
June 26, 2017
From medicinal plant extracts to defined chemical compounds targeting the histamine H<sub>4</sub> receptor: Curcuma longa in the treatment of inflammation
Annika Frank, Saleh Abu-Lafi, Azmi Adawi, et al.
Archiv Der Pharmazie
|
April 4, 2007
N-(4-(4-(2-Halogenophenyl)piperazin-1-yl)butyl) substituted cinnamoyl amide derivatives as dopamine D2 and D3 receptor ligands
Oliver Saur, Anneke E Hackling, Sylvie Perachon, et al.
Trends in Cell Biology
|
November 29, 2018
Posing the APC/C E3 Ubiquitin Ligase to Orchestrate Cell Division
Edmond R Watson, Nicholas G Brown, Jan-Michael Peters, et al.
Frontiers in Neuroscience
|
October 21, 2016
Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
Samuele Maramai, Sandra Gemma, Simone Brogi, et al.
Bioorganic & Medicinal Chemistry
|
February 10, 2006
Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists
Dorota Łazewska, Xavier Ligneau, Jean-Charles Schwartz, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
March 5, 2003
Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists
Susanna Liedtke, Karsten Flau, Markus Kathmann, et al.
ACS Chemical Neuroscience
|
January 29, 2026
Multitargeted Aza-Arylcarboxamides for Neurodegenerative Diseases: Potent Histamine H<sub>3</sub> Receptor Ligands with Anticholinesterase and Metal-Chelating Activities
Flavia B Lopes, Tobias Werner, Izilda A Bagatin, et al.
International Archives of Allergy and Immunology
|
November 20, 2013
Histamine downregulates the Th1-associated chemokine IP-10 in monocytes and myeloid dendritic cells
Franziska Glatzer, Susanne Mommert, Brigitta Köther, et al.
Page
of 49
Search research articles
Search
Showing results (221-230 of 485) with videos related to
Sort By:
Page
of 49
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
October 11, 2014
A search for functional histamine H4 receptors in the human, guinea pig and mouse brain
Monika Feliszek, Valerie Speckmann, Daniel Schacht, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 26, 2022
Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism
Nermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
June 26, 2017
From medicinal plant extracts to defined chemical compounds targeting the histamine H<sub>4</sub> receptor: Curcuma longa in the treatment of inflammation
Annika Frank, Saleh Abu-Lafi, Azmi Adawi, et al.
Archiv Der Pharmazie
|
April 4, 2007
N-(4-(4-(2-Halogenophenyl)piperazin-1-yl)butyl) substituted cinnamoyl amide derivatives as dopamine D2 and D3 receptor ligands
Oliver Saur, Anneke E Hackling, Sylvie Perachon, et al.
Trends in Cell Biology
|
November 29, 2018
Posing the APC/C E3 Ubiquitin Ligase to Orchestrate Cell Division
Edmond R Watson, Nicholas G Brown, Jan-Michael Peters, et al.
Frontiers in Neuroscience
|
October 21, 2016
Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
Samuele Maramai, Sandra Gemma, Simone Brogi, et al.
Bioorganic & Medicinal Chemistry
|
February 10, 2006
Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists
Dorota Łazewska, Xavier Ligneau, Jean-Charles Schwartz, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
March 5, 2003
Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists
Susanna Liedtke, Karsten Flau, Markus Kathmann, et al.
ACS Chemical Neuroscience
|
January 29, 2026
Multitargeted Aza-Arylcarboxamides for Neurodegenerative Diseases: Potent Histamine H<sub>3</sub> Receptor Ligands with Anticholinesterase and Metal-Chelating Activities
Flavia B Lopes, Tobias Werner, Izilda A Bagatin, et al.
International Archives of Allergy and Immunology
|
November 20, 2013
Histamine downregulates the Th1-associated chemokine IP-10 in monocytes and myeloid dendritic cells
Franziska Glatzer, Susanne Mommert, Brigitta Köther, et al.
Page
of 49